DTC Ads May Extend Product Life Without Rx-To-OTC Switch – Pfizer’s Gelbert
This article was originally published in The Tan Sheet
Executive Summary
An increase in DTC advertising and brand name recognition for Rx drugs may prevent companies from feeling an urgent need to switch their drugs over-the-counter upon patent expiration